These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24942714)

  • 1. Beta-blocking agents during electroconvulsive therapy: a review.
    Boere E; Birkenhäger TK; Groenland TH; van den Broek WW
    Br J Anaesth; 2014 Jul; 113(1):43-51. PubMed ID: 24942714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Landiolol and esmolol prevent tachycardia without altering cerebral blood flow.
    Saito S; Nishihara F; Akihiro T; Nishikawa K; Obata H; Goto F; Yuki N
    Can J Anaesth; 2005 Dec; 52(10):1027-34. PubMed ID: 16326671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Beta-blockers and electroconvulsive therapy: a review].
    van den Broek WW; Groenland TH; Mulder PG; Kusuma A; Birkenhäger TK; Pluijms EM; Bruijn JA
    Tijdschr Psychiatr; 2008; 50(4):205-15. PubMed ID: 18398800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of landiolol on hemodynamic response and seizure duration during electroconvulsive therapy.
    Nomoto K; Suzuki T; Serada K; Oe K; Yoshida T; Yamada S
    J Anesth; 2006; 20(3):183-7. PubMed ID: 16897237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Landiolol attenuates acute hemodynamic responses but does not reduce seizure duration during maintenance electroconvulsive therapy.
    Sakamoto A; Ogawa R; Suzuki H; Kimura M; Okubo Y; Fujiya T
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):630-5. PubMed ID: 15601388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of esmolol and labetalol to attenuate hyperdynamic states after electroconvulsive therapy.
    Castelli I; Steiner LA; Kaufmann MA; Alfillé PH; Schouten R; Welch CA; Drop LJ
    Anesth Analg; 1995 Mar; 80(3):557-61. PubMed ID: 7864425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esmolol reduces autonomic hypersensitivity and length of seizures induced by electroconvulsive therapy.
    Howie MB; Black HA; Zvara D; McSweeney TD; Martin DJ; Coffman JA
    Anesth Analg; 1990 Oct; 71(4):384-8. PubMed ID: 1975995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of esmolol and labetalol to attenuate haemodynamic responses after electroconvulsive therapy.
    Shrestha S; Shrestha BR; Thapa C; Pradhan SN; Thapa R; Adhikari S
    Kathmandu Univ Med J (KUMJ); 2007; 5(3):318-23. PubMed ID: 18604047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: I. Effectiveness of pretreatment regimens on hemodynamics.
    Weinger MB; Partridge BL; Hauger R; Mirow A
    Anesth Analg; 1991 Nov; 73(5):556-62. PubMed ID: 1952135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esmolol bolus and infusion attenuates increases in blood pressure and heart rate during electroconvulsive therapy.
    Kovac AL; Goto H; Arakawa K; Pardo MP
    Can J Anaesth; 1990 Jan; 37(1):58-62. PubMed ID: 1967227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two esmolol bolus doses on the haemodynamic response and seizure duration during electroconvulsive therapy.
    Kovac AL; Goto H; Pardo MP; Arakawa K
    Can J Anaesth; 1991 Mar; 38(2):204-9. PubMed ID: 1673645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labetalol in the control of cardiovascular responses to electroconvulsive therapy in high-risk depressed medical patients.
    Stoudemire A; Knos G; Gladson M; Markwalter H; Sung YF; Morris R; Cooper R
    J Clin Psychiatry; 1990 Dec; 51(12):508-12. PubMed ID: 2258364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hemodynamic effects of dexmedetomidine and esmolol in electroconvulsive therapy: a retrospective comparison.
    Aydogan MS; Yücel A; Begec Z; Colak YZ; Durmus M
    J ECT; 2013 Dec; 29(4):308-11. PubMed ID: 23774056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose esmolol bolus reduces seizure duration during electroconvulsive therapy: a double-blind, placebo-controlled study.
    van den Broek WW; Leentjens AF; Mulder PG; Kusuma A; Bruijn JA
    Br J Anaesth; 1999 Aug; 83(2):271-4. PubMed ID: 10618942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of esmolol pretreatment on EEG seizure morphology in RUL ECT.
    McCall WV; Zvara D; Brooker R; Arias L
    Convuls Ther; 1997 Sep; 13(3):175-80. PubMed ID: 9342133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolongation of QT interval induced by electroconvulsive therapy is attenuated by landiolol.
    Matsura M; Fujiwara Y; Ito H; Kandatsu N; Kato N; Harada J; Komatsu T
    J ECT; 2010 Mar; 26(1):37-40. PubMed ID: 20190601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of four pretreatment regimes on hemodynamics during electroconvulsive therapy: A double-blind randomized controlled crossover trial.
    Parikh DA; Garg SN; Dalvi NP; Surana PP; Sannakki D; Tendolkar BA
    Ann Card Anaesth; 2017; 20(1):93-99. PubMed ID: 28074804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Role of Ultrarapid Acting Betablocker Esmolol and Landiolol in Critically Ill Patients].
    Gassanov N; Er F
    Dtsch Med Wochenschr; 2019 Sep; 144(18):1280-1285. PubMed ID: 31514219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New ultra-short-acting beta-blockers: landiolol and esmolol--the effects on cardiovascular system].
    Mio Y
    Masui; 2006 Jul; 55(7):841-8. PubMed ID: 16856544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esmolol and landiolol, selective beta1-adrenoreceptor antagonists, provide neuroprotection against spinal cord ischemia and reperfusion in rats.
    Umehara S; Goyagi T; Nishikawa T; Tobe Y; Masaki Y
    Anesth Analg; 2010 Apr; 110(4):1133-7. PubMed ID: 20103544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.